DEPRENYL / SELEGILINE

(WikiLink: Deprenyl) - (Last Revision: 5/24/2022)

 
 

⫸ (−)Deprenyl (35) is an inhibitor of monoamine oxidase B (MAO B). It is known to up-regulate the activity of antioxidant enzymes SOD and CAT in the dopaminergic region of the brain. The drug is also the only chemical that has been repeatedly found to extend the lifespan of rats, mice, hamsters and dogs in animal models. In addition, the drug can also enhance antioxidant enzyme activity in tissues outside the brain, such as the adrenal glands, heart, kidneys, and spleen. The results showed that deprenyl can activate a variety of humoral factors (interferon-γ, tumor necrosis factor-α, interleukin-1β, 2, 6, etc.) and enhance the function of natural killer cells. These new observations of (−)deprenyl up-regulating SOD and CAT activities in the brain and in extra-brain vital organs involve anti-tumorigenic and immunomodulatory effects, it may be better explained by reports of significantly longer lifespan in experimental animals in the past. These combined drug effects may cause homeo- stasis regulation of the body’s neuro-immune-endocrine axis for protection against aging [154]. ⫷[1]

🔷 ? 🔷

4.3 ()Deprenyl
⫸(−)Deprenyl (35) is an inhibitor of monoamine oxidase B (MAO B). It is known to up-regulate the activity of antioxidant enzymes SOD and CAT in the dopaminer- gic region of the brain. The drug is also the only chemi- cal that has been repeatedly found to extend the lifespan of rats, mice, hamsters and dogs in animal models. In addition, the drug can also enhance antioxidant enzyme activity in tissues outside the brain, such as the adrenal glands, heart, kidneys, and spleen. The results showed that deprenyl can activate a variety of humoral factors (interferon-γ, tumor necrosis factor-α, interleukin-1β, 2, 6, etc.) and enhance the function of natural killer cells. These new observations of (−)deprenyl up-regulating SOD and CAT activities in the brain and in extra-brain vital organs involve anti-tumorigenic and immunomod- ulatory effects, it may be better explained by reports of significantly longer lifespan in experimental animals in the past. These combined drug effects may cause homeo- stasis regulation of the body’s neuro-immune-endocrine axis for protection against aging [154].⫷ [1]

🔷 ? 🔷

Interventional Opportunities

Format for Dosage, Change all Below

AIR AGENT

🔷 ? 🔷

TIME

🔷 ? 🔷

DOSAGE

🔷 ? 🔷

ROUTE

🔷 ? 🔷

INTERVAL

🔷 ? 🔷




With Food

🔷 ? 🔷

IConcomitant / Synergistic / Additive

🔷 ? 🔷

NOTES:

🔷 ? 🔷

🔷 ? 🔷

🔷 ? 🔷

🔷 ? 🔷

🔷 ? 🔷

🔷 ? 🔷

[1] [2022] Antiaging agents: safe interventions to slow aging and healthy life span extension

(−)-Deprenyl, A Selective MAO-B Inhibitor, with Apoptotic and Anti-apoptotic Properties

Why (−)deprenyl prolongs survivals of experimental animals: Increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects

Maintenance on l-deprenyl prolongs life in aged male rats

The significance of selegiline/(−)-deprenyl after 50 years in research and therapy (1965–2015)

[2001] Antiaging Compounds: (–)Deprenyl (Selegiline) and (–)1-(Benzofuran-2-yl)-2-propylaminopentane, [(–)BPAP], a Selective Highly Potent Enhancer of the Impulse Propagation Mediated Release
of Catecholamines and Serotonin in the Brain

[1996] Deprenyl Controversy

[2016] The Most Sought-After Anti-Aging Drug

[2021] Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice

[2021] Deprenyl, an old drug with new anticancer potential: Mini review

[2021] Sirtuins and Renal Oxidative Stress

[2021] Monoamine oxidases in age-associated diseases: New perspectives for old enzymes

[2022] Carving the senescent phenotype by the chemical reactivity of catecholamines: An integrative review

[2021] Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress

[2022] Antiaging agents: safe interventions to slow aging and healthy life span extension

[2021] Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases

🔷 ? 🔷